Therapeutic effects of Tanshinone IIA and Tetramethylpyrazine nanoemulsions on cognitive impairment and neuronal damage in Alzheimer's disease rat models

被引：0
|
作者：
Fang, Liang [1 ,2 ,3 ,4 ,5 ]
Cheng, Hongyan [1 ,2 ,3 ,4 ,5 ]
Chen, Weidong [1 ,2 ,3 ,4 ,5 ]
Peng, Can [1 ,2 ,3 ,4 ,5 ]
Liu, Yuanxu [1 ,2 ,3 ,4 ,5 ]
Zhang, Caiyun [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Anhui Univ Chinese Med, Sch Pharm, Anhui Prov Key Lab Pharmaceut Preparat Technol & A, Hefei 230012, Anhui, Peoples R China
[2] Anhui Educ Dept AUCM, Engn Technol Res Ctr Modernized Pharmaceut, Hefei 230012, Anhui, Peoples R China
[3] Anhui Univ Chinese Med, Inst Pharmacokinet, Hefei 230012, Anhui, Peoples R China
[4] Anhui Genuine Chinese Med Mat Qual Improvement Col, Hefei 230012, Anhui, Peoples R China
[5] Anhui Univ Chinese Med, Anhui Acad Chinese Med, Hefei 230012, Peoples R China
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 2024年 / 76卷 / 09期
关键词：
brain-targeted nanodrug delivery system; Alzheimer's disease; oxidative stress injury; neuronal apoptosis; MAPK/ERK/CREB signaling pathway; OXIDATIVE STRESS; NEUROINFLAMMATION; DYSFUNCTION; PROTECTS; DEFICITS; PATHWAY; TRANS;
D O I：
10.1093/jpp/rgae069
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Objectives The aim of this study was to investigate the therapeutic effects and related mechanisms of Tanshinone IIA and Tetramethylpyrazine O/W composite nanoemulsions on Alzheimer's disease (AD) rats.Methods The therapeutic effect of TSN/TMP O/W NEs on AD rats was evaluated by behavioral tests, H&E, Nissl, and Immunohistochemistry staining. ELISA and Western blot were used to analyze the mechanism.Key findings The results showed that TSN/TMP O/W NEs could down-regulate the expression of Bax and Caspase-3 proteins, decrease the level of MDA, increase the expression of SOD and GSH-Px, and alleviate cognitive impairment in AD rats.Conclusions TSN/TMP O/W NEs can inhibit MAPK/ERK/CREB signaling pathway and effectively alleviate cognitive impairment, oxidative stress injury, and neuronal apoptosis in AD rats.
引用
收藏
页码：1169 / 1177
页数：9
相关论文
共 50 条
  • [11] Oxidative Damage and Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment
    Baldeiras, Ines
    Santana, Isabel
    Proenca, Maria Teresa
    Garrucho, Maria Helena
    Pascoal, Rui
    Rodrigues, Ana
    Duro, Diana
    Oliveira, Catarina Resende
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (04) : 1165 - 1177
  • [12] Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment
    Beal, MF
    NEUROBIOLOGY OF AGING, 2005, 26 (05) : 585 - 586
  • [13] Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
    Mangialasche, Francesca
    Polidori, M. Cristina
    Monastero, Roberto
    Ercolani, Sara
    Camarda, Cecilia
    Cecchetti, Roberta
    Mecocci, Patrizia
    AGEING RESEARCH REVIEWS, 2009, 8 (04) : 285 - 305
  • [14] Evaluation of therapeutic effects of tetramethylpyrazine nitrone in Alzheimer's disease mouse model and proteomics analysis
    Zhou, Xinhua
    Huang, Kaipeng
    Wang, Yuqiang
    Zhang, Zaijun
    Liu, Yingying
    Hou, Qinghua
    Yang, Xifei
    Hoi, Maggie Pui Man
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [15] Peripheral oxidative damage in Mild Cognitive Impairment and mild Alzheimer's disease
    Baldeiras, Ines
    Santana, Isabel
    Proenca, Maria Teresa
    Garrucho, Maria Helena
    Pascoal, Rui
    Rodrigues, Ana
    Duro, Diana
    Oliveira, Catarina Resende
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 15 (01) : 117 - 128
  • [16] Therapeutic Effects of Multifunctional Tetramethylpyrazine Nitrone on Models of Parkinson's Disease in Vitro and in Vivo
    Guo, Baojian
    Xu, Daping
    Duan, Hongwei
    Du, Jing
    Zhang, Zaijun
    Lee, Simon MingYuen
    Wang, Yuqiang
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (02) : 274 - 285
  • [17] Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease
    Kapogiannis, Dimitrios
    Mattson, Mark P.
    LANCET NEUROLOGY, 2011, 10 (02): : 187 - 198
  • [18] Upregulation effects of Tanshinone IIA on the expressions of NeuN, Nissl body, and IκB and downregulation effects on the expressions of GFAP and NF-κB in the brain tissues of rat models of Alzheimer's disease
    Li, Jian
    Wen, Pu-yuan
    Li, Wen-wen
    Zhou, Jun
    NEUROREPORT, 2015, 26 (13) : 758 - 766
  • [19] Clinical effects of the NChinpi on the cognitive impairment of patients with Alzheimer's disease
    Seki, Takashi
    Meguro, Kenichi
    Yamakuni, Tohru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 51P - 51P
  • [20] The effects of bioactive compounds on Alzheimer's disease and Mild cognitive impairment
    McAnany, Brian
    Martirosyan, Danik
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2016, 6 (06): : 329 - 343
12345